These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20380491)

  • 1. Candidate selection for prostate cancer focal therapy.
    Taneja SS; Mason M
    J Endourol; 2010 May; 24(5):835-41. PubMed ID: 20380491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating localized prostate cancer and identifying candidates for focal therapy.
    Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
    Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.
    Eggener SE; Scardino PT; Carroll PR; Zelefsky MJ; Sartor O; Hricak H; Wheeler TM; Fine SW; Trachtenberg J; Rubin MA; Ohori M; Kuroiwa K; Rossignol M; Abenhaim L;
    J Urol; 2007 Dec; 178(6):2260-7. PubMed ID: 17936815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal therapy in prostate cancer-report from a consensus panel.
    de la Rosette J; Ahmed H; Barentsz J; Johansen TB; Brausi M; Emberton M; Frauscher F; Greene D; Harisinghani M; Haustermans K; Heidenreich A; Kovacs G; Mason M; Montironi R; Mouraviev V; de Reijke T; Taneja S; Thuroff S; Tombal B; Trachtenberg J; Wijkstra H; Polascik T
    J Endourol; 2010 May; 24(5):775-80. PubMed ID: 20477543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active surveillance for prostate cancer: can we modernize contemporary protocols to improve patient selection and outcomes in the focal therapy era?
    Tay KJ; Mendez M; Moul JW; Polascik TJ
    Curr Opin Urol; 2015 May; 25(3):185-90. PubMed ID: 25768694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
    Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
    BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supporting prostate cancer focal therapy: a multidisciplinary International Consensus of Experts ("ICE").
    Reis LO; Billis A; Zequi SC; Tobias-Machado M; Viana P; Cerqueira M; Ward JF
    Aging Male; 2014 Jun; 17(2):66-71. PubMed ID: 24597940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate biopsy in selecting candidates for hemiablative focal therapy.
    Tsivian M; Hruza M; Mouraviev V; Rassweiler J; Polascik TJ
    J Endourol; 2010 May; 24(5):849-53. PubMed ID: 20370327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New treatments for localized prostate cancer.
    Marberger M; Carroll PR; Zelefsky MJ; Coleman JA; Hricak H; Scardino PT; Abenhaim LL
    Urology; 2008 Dec; 72(6 Suppl):S36-43. PubMed ID: 19095127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology of prostate cancer and focal therapy ('male lumpectomy').
    Mazzucchelli R; Scarpelli M; Cheng L; Lopez-Beltran A; Galosi AB; Kirkali Z; Montironi R
    Anticancer Res; 2009 Dec; 29(12):5155-61. PubMed ID: 20044631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are we able to correctly identify prostate cancer patients who could be adequately treated by focal therapy?
    Katz B; Srougi M; Dall'Oglio M; Nesrallah AJ; Sant'anna AC; Pontes J; Reis ST; Sañudo A; Camara-Lopes LH; Leite KR
    Urol Oncol; 2012; 30(6):794-7. PubMed ID: 21458310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer?
    Tareen B; Godoy G; Sankin A; Temkin S; Lepor H; Taneja SS
    BJU Int; 2009 Jul; 104(2):195-9. PubMed ID: 19191784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary results of focal therapy for prostate cancer using cryoablation.
    Mouraviev V; Johansen TE; Polascik TJ
    J Endourol; 2010 May; 24(5):827-34. PubMed ID: 20443724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to select the right patients for focal therapy of prostate cancer?
    Passoni NM; Polascik TJ
    Curr Opin Urol; 2014 May; 24(3):203-8. PubMed ID: 24625428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer.
    Ahmed HU; Akin O; Coleman JA; Crane S; Emberton M; Goldenberg L; Hricak H; Kattan MW; Kurhanewicz J; Moore CM; Parker C; Polascik TJ; Scardino P; van As N; Villers A;
    BJU Int; 2012 Jun; 109(11):1636-47. PubMed ID: 22077593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of multiparametric MRI and transperineal template-guided mapping biopsy of the prostate to identify candidates for hemi-ablative focal therapy.
    Tran M; Thompson J; Böhm M; Pulbrook M; Moses D; Shnier R; Brenner P; Delprado W; Haynes AM; Savdie R; Stricker PD
    BJU Int; 2016 Jan; 117(1):48-54. PubMed ID: 25682968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of transperineal template biopsies of the prostate in the diagnosis of prostate cancer: a review.
    Abdulmajed MI; Hughes D; Shergill IS
    Expert Rev Med Devices; 2015 Mar; 12(2):175-82. PubMed ID: 25496525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medium-term oncological outcomes for extended vs saturation biopsy and transrectal vs transperineal biopsy in active surveillance for prostate cancer.
    Thompson JE; Hayen A; Landau A; Haynes AM; Kalapara A; Ischia J; Matthews J; Frydenberg M; Stricker PD
    BJU Int; 2015 Jun; 115(6):884-91. PubMed ID: 24989062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient selection for focal therapy of localized prostate cancer.
    Jayram G; Eggener SE
    Curr Opin Urol; 2009 May; 19(3):268-73. PubMed ID: 19342957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active surveillance for low-risk prostate cancer: selection of patients and predictors of progression.
    Dall'Era MA; Konety BR
    Nat Clin Pract Urol; 2008 May; 5(5):277-83. PubMed ID: 18285752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.